Radiobiological factors determining the radiosensitivity of radioresistant cancer cells

决定放射抗性癌细胞放射敏感性的放射生物学因素

基本信息

  • 批准号:
    06670906
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

In an attempt to elucidate the mechanism of radioresistance in melanoma cells, we demonstrated the following facts in the experimental system using human and murine melanoma cells : (1) the radiation dose-survival curve in melanoma cells had a larger shoulder portion in the low dose region, showing a marked radioresistance to doses commonly used in the conventional fractionated radiotherapy ; (2) melanoma cells showed a prominent repair of potentially lethal damage (PLD) after irradiation ; (3) melanoma cells had a relatively high fraction of S-phase cells which were more radioresistant than other phase cells in the cell cycle ; and, (4) pretreatment of melanoma cells with L-dopa significantly reduced the capacity for sublethal radiation damage in melanoma cells.On the basis of these results, we have studied the cell kinetics, melanin production, GSH metabolism, and DNA repair, so as to further elucidate the mechanism of radioresistance of melanoma cells. All of melanin-producing melanoma cell lines showede a larger shoulder portion in the low dose region and a larger repair of PLD in various conditioned examined. The synchronized culture method demonstrated the change of radiosensitivity during the cell cycle and the survival curves of cells in each phase of the cell cycle. GSH levels and GSH-related enzymes activity were examined, suggesting the relationship between the GSH metabolism and radiosensitivity. Further, unscheduled DNA synthesis (UDS) after irradiation were also examined, so as to elucidate the relationship between the DNA repair and radiosensitivity.
为了阐明黑色素瘤细胞的放射抵抗机制,我们在使用人和小鼠黑色素瘤细胞的实验系统中证明了以下事实:(1)黑色素瘤细胞的放射剂量-生存曲线在低剂量区域有较大的肩部,显示出对常规分割放射治疗中常用剂量的明显放射抵抗; (2) 黑色素瘤细胞在照射后表现出显着的潜在致命损伤(PLD)修复; (3)黑色素瘤细胞中S期细胞比例相对较高,其比细胞周期中其他期细胞更具有抗辐射能力; (4)左旋多巴预处理黑色素瘤细胞,显着降低黑色素瘤细胞亚致死辐射损伤的能力。在此基础上,我们对细胞动力学、黑色素生成、谷胱甘肽代谢和DNA修复等进行了研究,以进一步阐明黑色素瘤细胞的放射抵抗机制。所有产生黑色素的黑色素瘤细胞系在低剂量区域均显示出较大的肩部,并且在各种条件检查中显示出较大的 PLD 修复。同步培养方法展示了细胞周期过程中放射敏感性的变化以及细胞周期各时相细胞的存活曲线。检查 GSH 水平和 GSH 相关酶活性,提示 GSH 代谢与放射敏感性之间的关系。此外,还检查了照射后的非计划DNA合成(UDS),以阐明DNA修复与放射敏感性之间的关系。

项目成果

期刊论文数量(74)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamada, I., Numano, F., Suzuki, S: "Takayasu arteritis : evaluation with MR imaging" Radiology. 188. 89-94 (1993)
Yamada, I.、Numano, F.、Suzuki, S:“Takayasu 动脉炎:MR 成像评估”放射学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ichiro Yamada: "Year Book of Rheumatology" Sergent,J.S.,ed.,Mosby Inc.,Chicago(in press),
Ichiro Yamada:《风湿病学年鉴》Sergent,J.S.,ed.,Mosby Inc.,芝加哥(印刷中),
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ichiro Yamada: "Year Book of Neuroradiology" Grossman,R.,ed.,Mosby Inc.,Chicago(in press), (1996)
Ichiro Yamada:《神经放射学年鉴》Grossman, R.,ed.,Mosby Inc.,芝加哥(印刷中),(1996 年)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamada, I., Suzuki, S., Matsushima, Y: "Moyamoya disease : comparison of assessment with MR angiography and MR imaging versus conventional angiography" Radiology. 196. 211-218 (1995)
Yamada, I.、Suzuki, S.、Matsushima, Y:“烟雾病:MR 血管造影和 MR 成像与传统血管造影的评估比较”放射学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamada, I., Suzuki, S: "Primary uterine lymphoma : MR imaging" Amer.J.Roentgenol. 160. 662-663 (1993)
Yamada, I.,Suzuki, S:“原发性子宫淋巴瘤:MR 成像”Amer.J.Roentgenol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMADA Ichiro其他文献

YAMADA Ichiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMADA Ichiro', 18)}}的其他基金

Study on high-resolution MR microimaging using QSI and DTI
基于 QSI 和 DTI 的高分辨率 MR 显微成像研究
  • 批准号:
    15K09915
  • 财政年份:
    2015
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on the development and clinical utility of high-resolution MR endoscopy
高分辨率磁共振内窥镜的发展及临床应用研究
  • 批准号:
    23591753
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Control System of Product development in Holizontal Network Organization
横向网络组织产品开发控制体系
  • 批准号:
    23530580
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development and clinical application of MR endoscopy
磁共振内窥镜的发展及临床应用
  • 批准号:
    15591260
  • 财政年份:
    2003
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of MR endoscopy : basic and clinical investigations
MR内窥镜的发展:基础和临床研究
  • 批准号:
    10557085
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Optimization of contrast-enhanced MR angiography : basic and clinical investigations
对比增强磁共振血管造影的优化:基础和临床研究
  • 批准号:
    10670830
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Development of a cancer immunoregenerative therapy that blocks function-suppressive RNA editing signals from cancer cells to immune cells.
开发一种癌症免疫再生疗法,阻断从癌细胞到免疫细胞的功能抑制性 RNA 编辑信号。
  • 批准号:
    23K08173
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Induction of Paraptosis in Cancer Cells by Triptycene-Peptide Hybrids and Its Mechanistic Study
三蝶烯肽杂交体诱导癌细胞凋亡及其机制研究
  • 批准号:
    23K06056
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of molecular mechanisms of interaction between colorectal cancer cells and stromal cells in tumor budding area
阐明结直肠癌细胞与肿瘤出芽区基质细胞相互作用的分子机制
  • 批准号:
    23K15489
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Study on the Mechanisms of the Induction of Mesenchymal Cancer Cells and Their Plasticity and Diversity
间充质癌细胞诱导机制及其可塑性和多样性的研究
  • 批准号:
    23H05486
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
KRAS 抑制剂可引发巨噬细胞介导的破坏癌细胞
  • 批准号:
    10638364
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Development of fluorescence imaging technology of LAT1-expressing cancer cells using intracellular click reaction
利用细胞内点击反应开发表达 LAT1 的癌细胞荧光成像技术
  • 批准号:
    23KJ0588
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of anticancer drug candidates from natural products target for pancreatic cancer cells
从天然产物中开发针对胰腺癌细胞的抗癌候选药物
  • 批准号:
    23K14377
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the acquisition mechanism of radiation resistance of cancer cells by changes in osmotic pressure and its application to radiotherapy
通过渗透压变化阐明癌细胞耐辐射能力的获得机制及其在放射治疗中的应用
  • 批准号:
    23K14929
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Primary prostate cancer cells as novel models for patient therapy prediction
原发性前列腺癌细胞作为患者治疗预测的新模型
  • 批准号:
    477987
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Operating Grants
Fibroblasts Support the Growth of Brain Metastasis by Rendering Cancer Cells Resistant to Chemotherapy and Inducing Immunosuppression in Tumor Microenvironment
成纤维细胞通过使癌细胞对化疗产生抵抗并在肿瘤微环境中诱导免疫抑制来支持脑转移瘤的生长
  • 批准号:
    10735448
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了